HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Margot A Cousin Selected Research

Malignant hyperthermia susceptibility type 1

5/2017Whole exome sequencing of a patient with suspected mitochondrial myopathy reveals novel compound heterozygous variants in RYR1.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Margot A Cousin Research Topics

Disease

2Cytopenia
01/2019 - 01/2018
2Kleefstra Syndrome
03/2017 - 01/2017
2Loeys-Dietz Syndrome
01/2017 - 01/2017
2Tobacco Use Disorder (Nicotine Dependence)
12/2015 - 01/2014
1Infections
01/2022
1Pneumonia (Pneumonitis)
01/2022
1Granuloma
01/2022
1Hemolysis
01/2021
1Thrombotic Microangiopathies
01/2021
1Pre-Eclampsia (Preeclampsia)
01/2021
1Eclampsia
01/2021
1HELLP Syndrome
01/2021
1Undiagnosed Diseases
01/2021
1Autism Spectrum Disorder
01/2020
1Neurodegenerative Diseases (Neurodegenerative Disease)
01/2020
1Congenital Bone Marrow Failure Syndromes
01/2019
1Epilepsy (Aura)
11/2018
1IgA Deficiency
01/2018
1Sotos Syndrome
01/2018
1Fibrosis (Cirrhosis)
01/2018
1Ehlers-Danlos Syndrome (Syndrome, Ehlers-Danlos)
01/2018
1Bone Marrow Failure Disorders
01/2018
1Congenital Structural Myopathies (Centronuclear Myopathy)
05/2017
1Muscular Diseases (Myopathy)
05/2017
1Minicore Myopathy with External Ophthalmoplegia
05/2017
1Central Core Myopathy (Central Core Disease)
05/2017
1Malignant hyperthermia susceptibility type 1
05/2017
1Mitochondrial Myopathies (Mitochondrial Myopathy)
05/2017
1Marfan Syndrome (Marfan's Syndrome)
01/2017
1Neoplasms (Cancer)
01/2017
1Neurodevelopmental Disorders
01/2017
1Tremor (Tremors)
12/2016
1Dystonia (Limb Dystonia)
12/2016
1Alexander Disease (Alexander's Disease)
01/2016
1Parkinson Disease (Parkinson's Disease)
12/2015
1Erectile Dysfunction
12/2015
1Triploidy
02/2010

Drug/Important Bio-Agent (IBA)

3Transforming Growth Factor-beta Type II ReceptorIBA
01/2017 - 01/2017
2Proteins (Proteins, Gene)FDA Link
01/2021 - 01/2018
2Complement System Proteins (Complement)IBA
01/2021 - 02/2010
2DNA (Deoxyribonucleic Acid)IBA
01/2018 - 01/2017
2Histones (Histone)IBA
03/2017 - 01/2017
2Phosphotransferases (Kinase)IBA
01/2017 - 01/2017
2Pharmaceutical PreparationsIBA
12/2015 - 01/2014
1Oxidants (Oxidizing Agents)IBA
01/2022
1EnzymesIBA
01/2021
1Biological ProductsIBA
01/2021
1Complement C5 (Complement 5)IBA
01/2021
1Transcription Factors (Transcription Factor)IBA
01/2020
1RNA Polymerase IIIIBA
01/2020
12,5- dibromo- 2- (beta- naphthyl)indan- 1,3- dioneIBA
01/2019
1N 30IBA
01/2019
1CalciumIBA
11/2018
1CarboxypeptidasesIBA
01/2018
1Histone MethyltransferasesIBA
01/2018
1MethyltransferasesIBA
01/2018
1alpha-Fetoproteins (alpha-Fetoprotein)IBA
01/2018
1Immunoglobulin M (IgM)IBA
01/2018
1Danazol (Azol)FDA LinkGeneric
01/2018
1CollagenIBA
01/2018
1Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA
05/2017
1Phospholipid Transfer ProteinsIBA
12/2016
1Protein AggregatesIBA
01/2016
1Dopamine Agonists (Dopamine Agonist)IBA
12/2015
1ApomorphineFDA Link
12/2015
1NicotineFDA Link
12/2015

Therapy/Procedure

3Precision Medicine
01/2021 - 01/2016
1Lung Transplantation
01/2018
1Therapeutics
01/2018
1Hip Replacement Arthroplasty (Total Hip Replacement)
12/2016